Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders.
Clinical trial NCT07363603 · RECRUITING
Trial details
- NCT number
- NCT07363603
- Sponsor
- Pirogov Russian National Research Medical University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-09
- Primary completion
- 2026-12-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.